- LivaNova raised full-year 2026 revenue growth guidance range by 100 bps.
LivaNova raised its full-year 2026 revenue growth guidance by 100 basis points to 9-10% on a constant-currency basis. The upgrade points to stronger demand and operational momentum for the medical-device company.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.